Ametris

Ametris, formerly ActiGraph and now a Signant Health company, develops wearable digital health technology to support the transformation of clinical research. Its integrated solutions help research teams collect and interpret continuous, objective data about how participants function in everyday life, turning nuanced patient information into clinically meaningful measures.

The company offers medical-grade wearable devices and remote-monitoring platforms, including the CentrePoint® Platform and the Ametris Connect™ platform. Its digital measures cover physical activity, gait and mobility, sleep, behavior, vital signs, and symptoms, with capabilities such as cough detection and adverse-event monitoring. Ametris also provides algorithm and digital-outcome tools, patient engagement and adherence monitoring, and digital health operations.

Beyond technology, Ametris supports trials with scientific and operational services, including endpoint design, algorithm validation, data analytics, regulatory science, site training, logistics, and study monitoring. Its expertise spans therapeutic areas such as cardiology, oncology, neurology, respiratory conditions, obesity, and sleep disorders. By combining devices, software, and specialist support across the trial lifecycle, Ametris helps teams pursue patient-centered measurements and strengthen evidence for drug development.